PMID- 25389767 OWN - NLM STAT- MEDLINE DCOM- 20160429 LR - 20181113 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 9 IP - 11 DP - 2014 TI - Preventive effect of Daiokanzoto (TJ-84) on 5-fluorouracil-induced human gingival cell death through the inhibition of reactive oxygen species production. PG - e112689 LID - 10.1371/journal.pone.0112689 [doi] LID - e112689 AB - Daiokanzoto (TJ-84) is a traditional Japanese herbal medicine (Kampo formulation). While many Kampo formulations have been reported to regulate inflammation and immune responses in oral mucosa, there is no evidence to show that TJ-84 has beneficial effects on oral mucositis, a disease resulting from increased cell death induced by chemotherapeutic agents such as 5-fluorouracil (5-FU). In order to develop effective new therapeutic strategies for treating oral mucositis, we investigated (i) the mechanisms by which 5-FU induces the death of human gingival cells and (ii) the effects of TJ-84 on biological events induced by 5-FU. 5-FU-induced lactate dehydrogenase (LDH) release and pore formation in gingival cells (Sa3 cell line) resulted in cell death. Incubating the cells with 5-FU increased the expression of nucleotide-binding domain and leucine-rich repeat containing PYD-3 (NLRP3) and caspase-1. The cleavage of caspase-1 was observed in 5-FU-treated cells, which was followed by an increased secretion of interleukin (IL)-1beta. The inhibition of the NLRP3 pathway slightly decreased the effects of 5-FU on cell viability and LDH release, suggesting that NLRP3 may be in part involved in 5-FU-induced cell death. TJ-84 decreased 5-FU-induced LDH release and cell death and also significantly inhibited the depolarization of mitochondria and the up-regulation of 5-FU-induced reactive oxygen species (ROS) and nitric oxide (NO) production. The transcriptional factor, nuclear factor-kappaB (NF-kappaB) was not involved in the 5-FU-induced cell death in Sa3 cells. In conclusion, we provide evidence suggesting that the increase of ROS production in mitochondria, rather than NLRP3 activation, was considered to be associated with the cell death induced by 5-FU. The results also suggested that TJ-84 may attenuate 5-FU-induced cell death through the inhibition of mitochondrial ROS production. FAU - Yoshida, Kaya AU - Yoshida K AD - Department of Oral Healthcare Education, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan. FAU - Yoshioka, Masami AU - Yoshioka M AD - Department of Oral Health Science and Social Welfare, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan. FAU - Okamura, Hirohiko AU - Okamura H AD - Department of Histology and Oral Histology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan. FAU - Moriyama, Satomi AU - Moriyama S AD - Department of Hygiene and Oral Health Science, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan. FAU - Kawazoe, Kazuyoshi AU - Kawazoe K AD - Department of Clinical Pharmacy, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan. FAU - Grenier, Daniel AU - Grenier D AD - Oral Ecology Research Group, Faculty of Dentistry, Laval University, Quebec City, QC, Canada. FAU - Hinode, Daisuke AU - Hinode D AD - Department of Hygiene and Oral Health Science, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20141112 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Drugs, Chinese Herbal) RN - 0 (Reactive Oxygen Species) RN - EC 3.4.22.36 (Caspase 1) RN - U3P01618RT (Fluorouracil) SB - IM MH - Caspase 1/metabolism MH - Cell Death/*drug effects/physiology MH - Drugs, Chinese Herbal/*pharmacology MH - Fluorouracil/*pharmacology MH - Gingiva/*drug effects/metabolism/pathology MH - Humans MH - Medicine, Kampo MH - Reactive Oxygen Species/*metabolism MH - Stomatitis/chemically induced/drug therapy/metabolism/pathology PMC - PMC4229234 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2014/11/13 06:00 MHDA- 2016/04/30 06:00 PMCR- 2014/11/12 CRDT- 2014/11/13 06:00 PHST- 2014/08/11 00:00 [received] PHST- 2014/10/09 00:00 [accepted] PHST- 2014/11/13 06:00 [entrez] PHST- 2014/11/13 06:00 [pubmed] PHST- 2016/04/30 06:00 [medline] PHST- 2014/11/12 00:00 [pmc-release] AID - PONE-D-14-36000 [pii] AID - 10.1371/journal.pone.0112689 [doi] PST - epublish SO - PLoS One. 2014 Nov 12;9(11):e112689. doi: 10.1371/journal.pone.0112689. eCollection 2014.